{"id":23117,"date":"2026-07-16T19:10:10","date_gmt":"2026-07-16T19:10:10","guid":{"rendered":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/07\/16\/zayiflama-igneleri-mucize-degil-dogru-tedavinin-bir-parcasi\/"},"modified":"2026-07-16T19:10:10","modified_gmt":"2026-07-16T19:10:10","slug":"zayiflama-igneleri-mucize-degil-dogru-tedavinin-bir-parcasi","status":"publish","type":"post","link":"https:\/\/akdenizolay.com.tr\/index.php\/2026\/07\/16\/zayiflama-igneleri-mucize-degil-dogru-tedavinin-bir-parcasi\/","title":{"rendered":"Zay\u0131flama i\u011fneleri mucize de\u011fil, do\u011fru tedavinin bir par\u00e7as\u0131"},"content":{"rendered":"\n

Atlas \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Fak\u00fcltesi Beslenme ve Diyetetik B\u00f6l\u00fcm\u00fc’nden Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, son y\u0131llarda obezite tedavisinde yayg\u0131nla\u015fan ve kamuoyunda “zay\u0131flama i\u011fnesi” olarak bilinen GLP-1 ve GIP temelli ila\u00e7larla ilgili \u00f6nemli bilgilendirmelerde bulundu. Kalkan, bu ila\u00e7lar\u0131n estetik ama\u00e7l\u0131 de\u011fil, kronik bir hastal\u0131k olan obezitenin tedavisi i\u00e7in geli\u015ftirildi\u011fini vurgulayarak, ya\u015fam tarz\u0131 de\u011fi\u015fiklikleriyle desteklenmeyen ila\u00e7 kullan\u0131m\u0131n\u0131n kal\u0131c\u0131 ba\u015far\u0131 sa\u011flamad\u0131\u011f\u0131n\u0131 belirtti.<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Son y\u0131llarda obezite tedavisinde \u00f6nemli bir d\u00f6n\u00fc\u015f\u00fcm ya\u015fan\u0131rken, kamuoyunda “zay\u0131flama i\u011fnesi” olarak bilinen ila\u00e7lar da en \u00e7ok konu\u015fulan sa\u011fl\u0131k ba\u015fl\u0131klar\u0131ndan biri haline geldi. Ancak bu yo\u011fun ilgi, beraberinde bilgi kirlili\u011fini ve ger\u00e7ek\u00e7i olmayan beklentileri de getiriyor.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Atlas \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Fak\u00fcltesi Beslenme ve Diyetetik B\u00f6l\u00fcm\u00fc’nden Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, zay\u0131flama i\u011fneleriyle ilgili merak edilenleri g\u00fcncel bilimsel veriler \u0131\u015f\u0131\u011f\u0131nda de\u011ferlendirdi.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Zay\u0131flama i\u011fneleri tokluk hormonlar\u0131n\u0131 taklit ederek etki g\u00f6steriyor<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, kamuoyunda zay\u0131flama i\u011fnesi olarak bilinen ila\u00e7lar\u0131n b\u00fcy\u00fck b\u00f6l\u00fcm\u00fcn\u00fcn inkretin bazl\u0131 ila\u00e7lar oldu\u011funu belirterek \u015fu bilgileri payla\u015ft\u0131:<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“Semaglutid ve tirzepatid etken maddeli ila\u00e7lar, ba\u011f\u0131rsaklardan yemek sonras\u0131nda salg\u0131lanan GLP-1 ve GIP isimli do\u011fal tokluk hormonlar\u0131n\u0131 taklit eder. G\u00fcn\u00fcm\u00fczde ba\u011f\u0131rsak, yaln\u0131zca bir sindirim organ\u0131 de\u011fil, v\u00fccudun enerji dengesini d\u00fczenleyen \u00f6nemli bir endokrin organ olarak de\u011ferlendirilmektedir. Bu ila\u00e7lar pankreastan kan \u015fekerine ba\u011fl\u0131 olarak ins\u00fclin sal\u0131n\u0131m\u0131n\u0131 art\u0131r\u0131rken mide bo\u015falmas\u0131n\u0131 geciktirir ve beyindeki i\u015ftah merkezlerini etkileyerek tokluk hissini uzat\u0131r. B\u00f6ylece g\u00fcnl\u00fck enerji al\u0131m\u0131 azal\u0131r.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Herkes kullanamaz, estetik ama\u00e7l\u0131 geli\u015ftirilmedi<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Kalkan, bu ila\u00e7lar\u0131n birka\u00e7 kilo vermek isteyen herkes i\u00e7in uygun olmad\u0131\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7izdi.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“S\u00f6z konusu ila\u00e7lar estetik ama\u00e7la birka\u00e7 kilogram vermek i\u00e7in de\u011fil, tip 2 diyabet ve obezite gibi kronik hastal\u0131klar\u0131n t\u0131bbi tedavisi i\u00e7in geli\u015ftirilmi\u015ftir.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Uluslararas\u0131 k\u0131lavuzlara g\u00f6re ila\u00e7lar\u0131n; ya\u015fam tarz\u0131 de\u011fi\u015fikli\u011finden yeterli fayda g\u00f6remeyen, beden k\u00fctle indeksi (BK\u0130) 30 kg\/m\u00b2 ve \u00fczerinde olan veya BK\u0130’si 27 kg\/m\u00b2’nin \u00fczerinde olup hipertansiyon, dislipidemi, uyku apnesi ya da kardiyovask\u00fcler hastal\u0131k gibi obeziteye e\u015flik eden en az bir hastal\u0131\u011f\u0131 bulunan eri\u015fkinlerde kullan\u0131lmas\u0131n\u0131n \u00f6nerildi\u011fini belirten Kalkan, tedavinin mutlaka hekim kontrol\u00fcnde y\u00fcr\u00fct\u00fclmesi gerekti\u011fini ifade etti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

En s\u0131k g\u00f6r\u00fclen yan etkiler sindirim sistemiyle ili\u015fkili<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Zay\u0131flama i\u011fnelerinin her ila\u00e7ta oldu\u011fu gibi yan etkileri bulundu\u011funu s\u00f6yleyen Kalkan, \u00f6zellikle tedavinin ilk haftalar\u0131nda bulant\u0131, kusma, ishal ve kab\u0131zl\u0131k gibi sindirim sistemi \u015fik\u00e2yetlerinin g\u00f6r\u00fclebildi\u011fini belirtti. Kalkan, “Yan etkiler \u00e7o\u011funlukla ilk 4-8 haftada ve doz art\u0131r\u0131m\u0131 d\u00f6nemlerinde ortaya \u00e7\u0131kar. V\u00fccut ilaca uyum sa\u011flad\u0131k\u00e7a genellikle azal\u0131r” dedi.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Belirli tiroid kanseri \u00f6yk\u00fcs\u00fc, ciddi pankreatit, tip 1 diyabet, gebelik ve emzirme gibi baz\u0131 durumlarda ila\u00e7lar\u0131n kullan\u0131lmamas\u0131 ya da \u00e7ok yak\u0131n takip gerektirdi\u011fini vurgulayan Kalkan, uygunlu\u011fun mutlaka hekim taraf\u0131ndan de\u011ferlendirilmesi gerekti\u011fini s\u00f6yledi.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Do\u011fru beslenme yan etkilerin hafiflemesine yard\u0131mc\u0131 oluyor<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Beslenme d\u00fczeninin tedavinin ayr\u0131lmaz bir par\u00e7as\u0131 oldu\u011funu belirten Kalkan, k\u00fc\u00e7\u00fck porsiyonlarla beslenmenin, yava\u015f yemek yemenin, \u00f6zellikle doz art\u0131r\u0131m zamanlard\u0131nda ya\u011fl\u0131 ve k\u0131zart\u0131lm\u0131\u015f besinlerden ka\u00e7\u0131nman\u0131n bulant\u0131y\u0131 azaltabilece\u011fini ifade etti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Kab\u0131zl\u0131k ya\u015fayan bireylerde s\u0131v\u0131 t\u00fcketiminin art\u0131r\u0131lmas\u0131 ve lif al\u0131m\u0131n\u0131n kademeli y\u00fckseltilmesinin; ishal durumunda ise ya\u011fl\u0131 ve \u00e7ok baharatl\u0131 besinlerin s\u0131n\u0131rland\u0131r\u0131lmas\u0131n\u0131n faydal\u0131 olabilece\u011fini belirten Kalkan, g\u00fcn i\u00e7ine yay\u0131lan yeterli s\u0131v\u0131 t\u00fcketiminin \u00f6nemine dikkat \u00e7ekti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Tart\u0131daki rakam de\u011fil, kaybedilen a\u011f\u0131rl\u0131\u011f\u0131n i\u00e7eri\u011fi \u00f6nemli<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, ila\u00e7larla verilen kilonun yaln\u0131zca ya\u011f dokusundan olu\u015fmad\u0131\u011f\u0131n\u0131 belirterek \u00f6nemli bir noktaya dikkat \u00e7ekti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“Ba\u015far\u0131l\u0131 bir kilo kayb\u0131nda \u00f6nemli olan sadece tart\u0131daki d\u00fc\u015f\u00fc\u015f de\u011fildir. As\u0131l \u00f6nemli olan kaybedilen a\u011f\u0131rl\u0131\u011f\u0131n ne kadar\u0131n\u0131n ya\u011fdan, ne kadar\u0131n\u0131n kas dokusundan geldi\u011fidir.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

\u0130\u015ftah azalmas\u0131yla birlikte protein al\u0131m\u0131n\u0131n da d\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc belirten Kalkan, bunun kas kayb\u0131n\u0131 art\u0131rabilece\u011fini s\u00f6yledi.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“Semaglutid ile yap\u0131lan STEP 1 \u00e7al\u0131\u015fmas\u0131n\u0131n v\u00fccut kompozisyonu analizinde kaybedilen a\u011f\u0131rl\u0131\u011f\u0131n yakla\u015f\u0131k y\u00fczde 35-40’\u0131n\u0131n ya\u011fs\u0131z dokudan, yani kas dahil dokulardan geldi\u011fi g\u00f6sterildi. Kas dokusunun kayb\u0131 bazal metabolizma h\u0131z\u0131n\u0131 d\u00fc\u015f\u00fcrebilir ve ilerleyen d\u00f6nemde a\u011f\u0131rl\u0131k geri kazan\u0131m\u0131n\u0131 kolayla\u015ft\u0131rabilir.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

\u0130la\u00e7 b\u0131rak\u0131ld\u0131\u011f\u0131nda kilo geri al\u0131m\u0131 g\u00f6r\u00fclebiliyor<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Kalkan, bilimsel \u00e7al\u0131\u015fmalar\u0131n ila\u00e7 b\u0131rak\u0131ld\u0131ktan sonra kilo geri al\u0131m\u0131n\u0131n s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc ortaya koydu\u011funu belirtti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“STEP 4 ve SURMOUNT-4 \u00e7al\u0131\u015fmalar\u0131nda ilaca devam eden bireylerin a\u011f\u0131rl\u0131k kayb\u0131n\u0131n devam etti\u011fi, tedaviyi b\u0131rakan gruplarda ise belirgin kilo geri al\u0131m\u0131 ya\u015fand\u0131\u011f\u0131 g\u00f6r\u00fcld\u00fc. <\/span><\/span><\/span>Bu geri al\u0131m, irade eksikli\u011finin de\u011fil, biyolojik bir s\u00fcrecin beklenen sonucudur; ki\u015filer ilac\u0131 b\u0131rakt\u0131\u011f\u0131nda hem daha fazla a\u00e7l\u0131k hisseder hem de daha az enerji harcar. Bu tablo, obezitenin kronik ve tekrarlayan bir hastal\u0131k oldu\u011funu bir kez daha ortaya koyar.\u201d<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Kas kayb\u0131 uzun vadede \u00f6nemli risk olu\u015fturuyor<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Tekrarlayan kilo verme ve geri alma d\u00f6ng\u00fclerinin zamanla v\u00fccut kompozisyonunu olumsuz etkileyebilece\u011fini belirten Kalkan, \u00f6zellikle ileri ya\u015flarda sarkopenik obezite riskine dikkat \u00e7ekti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

As\u0131l kritik noktan\u0131n uzun vadede ortaya \u00e7\u0131kt\u0131\u011f\u0131na dikkat \u00e7eken Kalkan, \u201c\u0130la\u00e7 b\u0131rak\u0131ld\u0131\u011f\u0131nda geri al\u0131nan a\u011f\u0131rl\u0131k daha \u00e7ok ya\u011f dokusundan olu\u015fur; kaybedilen kas ise ayn\u0131 kolayl\u0131kla geri kazan\u0131lmaz. Bu nedenle tekrarlayan verme-geri alma d\u00f6ng\u00fcleri zamanla v\u00fccuttaki ya\u011f oran\u0131n\u0131n artmas\u0131na ve kas oran\u0131n\u0131n gerilemesine yol a\u00e7abilir\u201d uyar\u0131s\u0131nda bulundu.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, \u015funlar\u0131 s\u00f6yledi: <\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

\u201c\u00d6zellikle ileri ya\u015fta ve s\u0131k tekrarlayan d\u00f6ng\u00fclerde bu durum; kas k\u00fctlesi ve g\u00fcc\u00fcn\u00fcn azald\u0131\u011f\u0131, buna kar\u015f\u0131n ya\u011f oran\u0131n\u0131n y\u00fcksek oldu\u011fu \u2018Sarkopenik obezite\u2019 tablosuna zemin haz\u0131rlayabilir. Obezitesi olan kad\u0131nlarda yap\u0131lan bir \u00e7al\u0131\u015fmada, a\u011f\u0131rl\u0131k kayb\u0131 s\u0131ras\u0131nda kaybedilen her 1 kg ya\u011fa kar\u015f\u0131l\u0131k 0,26 kg ya\u011fs\u0131z doku kaybedilirken, sonraki d\u00f6nemde geri al\u0131nan her 1 kg ya\u011fa kar\u015f\u0131l\u0131k yaln\u0131zca 0,12 kg ya\u011fs\u0131z doku geri kazan\u0131lm\u0131\u015ft\u0131r. <\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

K\u0131sacas\u0131 kas dokusu kaybedilirken kolay, yeniden kazan\u0131l\u0131rken zordur; bu da kas k\u00fctlesini en ba\u015ftan korumay\u0131 \u00e7ok daha \u00f6nemli k\u0131lar. Bu nedenle s\u00fcre\u00e7, en ba\u015f\u0131ndan itibaren diyetisyen taraf\u0131ndan bireye \u00f6zg\u00fc bir t\u0131bbi beslenme tedavisiyle planlanmal\u0131; hekim ve diyetisyenin birlikte y\u00fcr\u00fctt\u00fc\u011f\u00fc bir ekip yakla\u015f\u0131m\u0131yla d\u00fczenli olarak takip edilmelidir. Ayr\u0131ca tedaviye bir fizyoterapist e\u015fli\u011finde diren\u00e7 antrenman\u0131n\u0131n eklenmesi, kas k\u00fctlesinin korunmas\u0131na \u00f6nemli katk\u0131 sa\u011flar.\u201d<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Protein ve diren\u00e7 egzersizi tedavinin vazge\u00e7ilmezleri aras\u0131nda<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, GLP-1 tedavisi alan bireylerde yeterli protein al\u0131m\u0131 ve d\u00fczenli diren\u00e7 egzersizinin kas kayb\u0131n\u0131 \u00f6nlemek a\u00e7\u0131s\u0131ndan kritik oldu\u011funu belirtti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“\u0130\u015ftah azalmas\u0131 nedeniyle yaln\u0131zca enerji de\u011fil; karbonhidrat, protein, vitamin ve mineral al\u0131mlar\u0131 da d\u00fc\u015febiliyor. Bu nedenle beslenme plan\u0131 mutlaka ki\u015fiye \u00f6zel haz\u0131rlanmal\u0131, gerekti\u011finde B12 vitamini, demir, \u00e7inko, D vitamini, kalsiyum ve magnezyum gibi mikro besin \u00f6geleri a\u00e7\u0131s\u0131ndan d\u00fczenli takip yap\u0131lmal\u0131d\u0131r.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“\u0130la\u00e7lar ya\u015fam tarz\u0131 de\u011fi\u015fikli\u011finin yerine ge\u00e7mez”<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Tedavi s\u00fcrecinde yap\u0131lan en b\u00fcy\u00fck hatalardan birinin a\u015f\u0131r\u0131 d\u00fc\u015f\u00fck enerji al\u0131m\u0131 oldu\u011funu belirten Kalkan, \u00f6\u011f\u00fcn atlaman\u0131n kas kayb\u0131n\u0131 art\u0131rabilece\u011fini ifade etti.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“\u0130\u015ftah kontrol\u00fcn\u00fcn ki\u015filer taraf\u0131ndan sa\u011flanabilir hale gelmesi, sa\u011fl\u0131kl\u0131 beslenme al\u0131\u015fkanl\u0131klar\u0131n\u0131 kal\u0131c\u0131 hale getirmek i\u00e7in \u00f6nemli bir f\u0131rsatt\u0131r. <\/span><\/span><\/span>\u0130la\u00e7 b\u0131rak\u0131ld\u0131\u011f\u0131nda g\u00f6r\u00fclen a\u011f\u0131rl\u0131k geri al\u0131m\u0131n\u0131 s\u0131n\u0131rlaman\u0131n en etkili yolu da bu d\u00f6nemde kazan\u0131lan ya\u015fam tarz\u0131 de\u011fi\u015fiklikleridir. Nitekim STEP 3 \u00e7al\u0131\u015fmas\u0131nda semaglutid, diyetisyen e\u015fli\u011finde y\u00fcr\u00fct\u00fclen yo\u011fun bir ya\u015fam tarz\u0131 deste\u011fiyle birlikte yakla\u015f\u0131k y\u00fczde 16 a\u011f\u0131rl\u0131k kayb\u0131 sa\u011flarken, yaln\u0131zca ya\u015fam tarz\u0131 deste\u011fi alan grupta bu oran y\u00fczde 5,7’de kalm\u0131\u015ft\u0131r.<\/span><\/span><\/span><\/span> Bu nedenle ila\u00e7lar\u0131n kullan\u0131ld\u0131\u011f\u0131 d\u00f6nemde yetersiz beslenmek yerine s\u00fcrd\u00fcr\u00fclebilir ve dengeli bir beslenme d\u00fczeni olu\u015fturulmal\u0131d\u0131r.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

T\u00fcrkiye’de obezite oran\u0131 art\u0131yor<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Kalkan, T\u00dc\u0130K’in 2025 T\u00fcrkiye Sa\u011fl\u0131k Ara\u015ft\u0131rmas\u0131 verilerine g\u00f6re 15 ya\u015f ve \u00fczerindeki bireylerde obezite s\u0131kl\u0131\u011f\u0131n\u0131n y\u00fczde 21,8’e y\u00fckseldi\u011fini, kad\u0131nlarda bu oran\u0131n y\u00fczde 24,8, erkeklerde ise y\u00fczde 18,7 olarak bildirildi\u011fini hat\u0131rlatt\u0131.<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

Zay\u0131flama i\u011fneleri bir k\u0131sayol de\u011fil<\/span><\/span><\/span><\/b><\/span><\/span><\/span><\/p>\n

Dr. \u00d6\u011fr. \u00dcyesi G\u00fclen Ecem Kalkan, s\u00f6zlerini \u015fu de\u011ferlendirmeyle tamamlad\u0131:<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

“Bu ila\u00e7lar\u0131 ne tamamen reddetmek ne de mucize \u00e7\u00f6z\u00fcm olarak g\u00f6rmek do\u011fru yakla\u015f\u0131md\u0131r. Modern t\u0131p, obezite tedavisinde olduk\u00e7a etkili ila\u00e7 se\u00e7enekleri sunuyor. Ancak bu tedaviler beslenme d\u00fczeni, fiziksel aktivite ve davran\u0131\u015f de\u011fi\u015fikli\u011fiyle birlikte uyguland\u0131\u011f\u0131nda anlaml\u0131 ve s\u00fcrd\u00fcr\u00fclebilir sonu\u00e7 verir. Zay\u0131flama i\u011fneleri tek ba\u015f\u0131na bir \u00e7\u00f6z\u00fcm de\u011fil, do\u011fru planlanm\u0131\u015f multidisipliner tedavinin \u00f6nemli bir par\u00e7as\u0131d\u0131r.”<\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"

Atlas \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Fak\u00fcltesi Beslenme ve Diyetetik B\u00f6l\u00fcm\u00fc’nden Dr.<\/p>\n","protected":false},"author":1,"featured_media":23118,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-23117","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/23117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=23117"}],"version-history":[{"count":1,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/23117\/revisions"}],"predecessor-version":[{"id":23119,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/23117\/revisions\/23119"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media\/23118"}],"wp:attachment":[{"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=23117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=23117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/akdenizolay.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=23117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}